Ricevi le ultime notizie sulle azioni Rallybio con aggiornamenti su tendenze di mercato, dati finanziari e analisi di Benzinga. Rimani informato sulle performance di RLYB

Ultime notizie per

RALLYBIO CORP

Rallybio

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Rallybio Corp

Press Releases

Rallybio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Rallybio to Discontinue Development of RLYB212 for Prevention of FNAIT

Rallybio to Present at the 2025 Citizens JMP Life Sciences Conference

Rallybio Reports First Quarter 2025 Financial Results and Provides Business Updates

Rallybio Initiates Dosing in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study

Rallybio Sells Interest in REV102 Program to Recursion Pharmaceuticals

Health Care

Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia

Rallybio Reports Second Quarter 2025 Financial Results and Provides Business Updates

Rallybio Receives $12.5 Million Equity Milestone Payment from Recursion for Advancement of REV102 Program

Penny Stocks

Rallybio Completes Dosing of First Cohort in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study

RLYB

RXRX

Abpro Hldgs

Allarity Therapeutics, Inc. - Common stock

Allarity Therapeutics

Aptorum Group Limited - Class A Ordinary Shares

Aptorum Group

Apimeds Pharmaceuticals US, Inc. Common Stock

Apimeds Pharmaceuticals

BriaCell Therapeutics Corp. - Common Shares

BriaCell Therapeutics

Cellectar Biosciences, Inc. - Common Stock

Cellectar Biosciences

Curis

Edesa Biotech

FibroBiologics

CytoMed Therapeutics Limited - Ordinary Shares

CytoMed Therapeutics

Geovax Labs

iBio

Kairos Pharma

Longeveron

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Lisata Therapeutics

Moleculin Biotech

MetaVia

NextCure

Palisade Bio

ProMIS Neurosciences Inc. - Common Shares

ProMIS Neurosciences

Propanc Biopharma

SAB Biotherapeutics

Synlogic

Tharimmune

Evercore ISI Group

JMP Securities

Wedbush

Jefferies

Comments

Rallybio Notizie sulle azioni

Notizie

Ultime notizie per

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO